Fig. 1 | Scientific Reports

Fig. 1

From: A bioinformatics analysis and experimental validation of PDGFD as a promising diagnostic biomarker for acute myeloid leukemia

Fig. 1

The overall flow chart of our study. Step1: PDGFD was screened by pan-cancer analysis and analysis of the expression and prognostic significance in AML. Step2: Bioinformatics analysis of PDGFD, including clinical significance, immuno-infiltration, drug susceptibility, functional enrichment, single cell analysis, and prediction of target miRNA. Step3: Validation from clinical samples, including expression and clinical significance of PDGFD.

Back to article page